FIELD: medicine, phthisiology. SUBSTANCE: it is suggested to use roncoleukin immunocorrecting preparation at the background of isoniazide and rifampicin intake. The method enables to increase efficiency of therapy due to directed correction of Tx-1 function and IL-2 production and keep immunocorrector's activity at the background of rifampicin intake. EFFECT: higher efficiency of therapy. 4 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS | 2001 |
|
RU2229892C2 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS AT PREDOMINANTLY PRODUCTIVE TYPE OF TISSUE REACTION | 2000 |
|
RU2204409C2 |
AGENT ENHANCING EFFECTIVENESS OF TREATMENT OF PATIENTS WITH TUBERCULOSIS | 1996 |
|
RU2136276C1 |
METHOD FOR TREATMENT OF DESTRUCTIVE AND PROGRESSING LUNG TUBERCULOSIS FORMS CAUSED BY DRUG-RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS | 2000 |
|
RU2215538C2 |
METHOD OF TREATING PULMONARY TUBERCULOSIS FEATURING PREDOMINANTLY EXUDATIVE TYPE OF INFLAMMATION | 1990 |
|
RU2008902C1 |
IMMUNOMODULATING DRUG | 1996 |
|
RU2112543C1 |
METHOD FOR TREATING THE CASES OF RESPIRATORY ORGAN TUBERCULOSIS WITH MARKED EXUDATION RESPONSE IN CHILDREN | 2000 |
|
RU2189234C2 |
METHOD FOR TREATING TUBERCULAR EPIDIDYMITIS | 1999 |
|
RU2204391C2 |
RECOMBINANT INFLUENZA VIRUS STRAINS EXPRESSING MYCOBACTERIAL PROTECTIVE ESAT-6 ANTIGEN AND USES THEREOF IN TUBERCULOSIS TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2318872C2 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
Authors
Dates
2002-08-27—Published
1999-07-09—Filed